Compugen Ltd.
(TEL Aviv Stock Exchange : CGEN)

( )
CGEN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen, Inc.
-0.93%291.401.4%$865.23m
AMGNAmgen, Inc.
0.28%221.311.3%$495.03m
CELGCelgene Corp.
0.39%110.001.3%$448.97m
GILDGilead Sciences, Inc.
-0.50%64.321.0%$384.61m
ILMNIllumina, Inc.
0.25%295.733.5%$305.32m
VRTXVertex Pharmaceuticals, Inc.
0.97%203.861.9%$290.09m
REGNRegeneron Pharmaceuticals, Inc.
1.20%348.412.6%$262.04m
EXASEXACT Sciences Corp.
-0.77%79.9124.0%$196.13m
ALXNAlexion Pharmaceuticals, Inc.
0.39%109.442.0%$190.16m
SGENSeattle Genetics, Inc.
2.16%110.646.1%$126.52m
BMRNBioMarin Pharmaceutical, Inc.
0.73%75.884.3%$110.72m
SRPTSarepta Therapeutics, Inc.
5.46%99.9514.6%$106.88m
AAgilent Technologies, Inc.
0.26%77.051.6%$100.02m
MRTXMirati Therapeutics, Inc.
1.12%104.332.3%$89.09m
NBIXNeurocrine Biosciences, Inc.
0.50%111.405.0%$84.24m

Company Profile

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.